NM_001626.6(AKT2):c.1090A>G (p.Met364Val) AND multiple conditions
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Dec 20, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002913099.5
Allele description [Variation Report for NM_001626.6(AKT2):c.1090A>G (p.Met364Val)]
NM_001626.6(AKT2):c.1090A>G (p.Met364Val)
Condition(s)
- Name:
- Type 2 diabetes mellitus
- Synonyms:
- DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; Type II diabetes mellitus; Diabetes mellitus, noninsulin-dependent, late onset
- Identifiers:
- MONDO: MONDO:0005148; MeSH: D003924; MedGen: C0011860; OMIM: 125853; Human Phenotype Ontology: HP:0005978
-
BX420203 Homo sapiens FETAL BRAIN Homo sapiens cDNA clone CS0DF025YK13 3-PRIME, ...
BX420203 Homo sapiens FETAL BRAIN Homo sapiens cDNA clone CS0DF025YK13 3-PRIME, mRNA sequencegi|46928751|gnl|dbEST|22812552|emb| 203.2|Nucleotide
-
fibroblast growth factor 16 [Rattus norvegicus]
fibroblast growth factor 16 [Rattus norvegicus]gi|11177916|ref|NP_068639.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024